VAERS reports by lot

Moderna COVID-19 lot 041620A: VAERS reports

55 VAERS reports list lot 041620A as a Moderna COVID-19 vaccine, received between 2021-01-19 and 2023-07-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
55
Reports
15%
Marked serious
3
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5726%
Injection-site / Local reaction3516%
Musculoskeletal2712%
Neurological2512%
Gastrointestinal2110%
Dermatological (non-injection-site)167%
Cardiac / Cardiovascular146%
Respiratory105%
Allergic / Anaphylactic52%
Psychiatric / Neuropsychiatric42%
Thrombotic / Hematological21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Alabama11
California7
Minnesota6
Texas5
Oregon4
Mississippi3
Washington3
Alaska2
Missouri2
Arizona2
Puerto Rico1
Arkansas1

Reports by month received

2021-0110
2021-029
2021-036
2021-041
2021-051
2021-0818
2021-091
2021-113
2021-122
2022-051
2022-091
2022-101
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.